EDOC News and Press, Global X Telemedicine & Digital Health ETF From 03/10/25

2025-03-10 12:17:00 ET Summary Are these tariffs a short-term pressure tactic or a long-term shift in trade policy? Either way, they are reshaping global supply chains, creating new risks and opportunities for investors. The idea of a U.S. gold revaluation is making the rounds, th...

2025-02-28 05:20:00 ET Summary Many healthcare stocks have underperformed the S&P 500. There are some pockets of strength though. Risk of overregulation remains a headwind. Many stocks in the healthcare sector have trailed the wider markets, but are there pockets...

2025-02-27 00:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-02-25 11:06:00 ET Summary Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies? Even as ...

2025-02-24 11:43:00 ET Summary In a joint venture with Oracle, OpenAI, and Softbank, President Trump announced a new project called Stargate. U.S nuclear power provider Constellation Energy agreed to acquire natural gas and geothermal company Calpine Corp. for $16.4 billion. A...

2025-02-20 01:50:00 ET Summary Donald Trump's threat of 25% or more tariffs on pharmaceuticals imported to the US would be a bitter pill to swallow for both consumers and producers, as costs will increase particularly in the short run. We estimate that the US consumed ro...

2025-02-14 03:20:00 ET Summary In the U.S., Pharmacy Benefit Managers serve as middlemen between insurers, drug manufacturers, and pharmacies, primarily by negotiating rebates on medications and promoting the use of generic drugs. On the revenue side, PBMs get paid by insurance co...

2025-02-05 01:55:00 ET Summary Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly $1T in industry financial capacity. Strategic partnerships between tech and healthcare companies aim to unlock val...

2025-01-29 06:30:00 ET Summary Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking innovations like mRNA cancer vaccines and CRISPR-based therapies. Structural shifts, including operational discipline and AI-p...

2025-01-27 05:50:00 ET Summary The healthcare industry stands at a critical inflection point where traditional care delivery models can no longer keep pace with soaring demand. While preventative care approaches have shown promise in managing chronic conditions and improving patie...